(COV) Covivio - Ratings and Ratios

Covivio SA is a leading European real estate player that combines property expertise with a deep understanding of user needs, aiming to create innovative and attractive living and working spaces. With a strong presence across Europe and €23.1 billion in assets, the company is well-positioned to capitalize on the evolving demands of companies, hotel brands, and local authorities. Covivios focus on well-being, sustainability, and responsible performance is reflected in its comprehensive approach to real estate, encompassing work, travel, and living spaces.

The companys commitment to sustainability and social responsibility is evident in its inclusion in various ESG indices, such as FTSE4 Good, CAC SBT1.5°C, DJSI World and Europe, and Euronext Vigeo. Covivios shares are listed on Euronext Paris, and its financial reporting and sustainable development practices have been recognized with the EPRA BPRs Gold Awards. This strong ESG profile may attract investors seeking responsible investment opportunities.

From a technical analysis perspective, Covivios stock price is currently at €51.35, with a 20-day SMA of €50.79 and a 50-day SMA of €49.09, indicating a potential bullish trend. The 200-day SMA of €49.15 further supports this outlook. The ATR of 0.94 (€1.84% daily volatility) suggests moderate price movements. Given the current technical setup, a potential price target could be the 52-week high of €53.74, representing a 4.7% upside from current levels.

Fundamentally, Covivios market capitalization stands at €5.82 billion, with a P/E ratio of 83.41 and a forward P/E of 11.68. The significant difference between the current and forward P/E suggests potential earnings growth. However, the current RoE of -16.36% indicates that the company is currently facing challenges in generating returns for shareholders. If Covivio can address these challenges and achieve earnings growth, the stock may be poised for a rebound. Combining the technical and fundamental analysis, a potential forecast for Covivios stock price could be a rise to €55-€60 in the next 6-12 months, driven by a combination of earnings growth and a continued bullish trend.